Terms: = Prostate cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4
145 results:
1. Diagnostic accuracy of qualitative and quantitative magnetic resonance imaging-guided contrast-enhanced ultrasound (MRI-guided CEUS) for the detection of prostate cancer: a prospective and multicenter study.
Liu Y; Lu D; Xu G; Wang S; Zhou B; Zhang Y; Ye B; Xiang L; Zhang Y; Xu H
Radiol Med; 2024 Apr; 129(4):585-597. PubMed ID: 38512615
[TBL] [Abstract] [Full Text] [Related]
2. Bone-Modifying Agents in Patients With High-Risk Metastatic Castration-Sensitive prostate cancer Treated With Abiraterone Acetate.
Fukuokaya W; Mori K; Urabe F; Igarashi T; Yanagisawa T; Tsuzuki S; Honda M; Miki K; Kimura T
JAMA Netw Open; 2024 Mar; 7(3):e242467. PubMed ID: 38488793
[TBL] [Abstract] [Full Text] [Related]
3. The Efficacy of Ketoconazole Containing Regimens in Castration-Resistant prostate cancer: A Systematic Review and Meta-Analysis.
Rehman OU; Nadeem ZA; Fatima E; Akram U; Imran H; Husnain A; Nadeem A; Rasheed W
Clin Genitourin Cancer; 2024 Apr; 22(2):483-490.e5. PubMed ID: 38296679
[TBL] [Abstract] [Full Text] [Related]
4. Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells.
Saamarthy K; Ahlqvist K; Daams R; Balagunaseelan N; Rinaldo-Matthis A; Kazi JU; Sime W; Massoumi R
BMC Cancer; 2024 Jan; 24(1):103. PubMed ID: 38238702
[TBL] [Abstract] [Full Text] [Related]
5. Trends in Utilization and Medicare Spending on Short-Course Radiation Therapy for Breast and prostate cancer: An Episode-Based Analysis From 2015 to 2019.
Patel TA; Jain B; Vapiwala N; Chino F; Tringale KR; Mahal BA; Yamoah K; McBride SN; Lam MB; Hubbard A; Nguyen PL; Dee EC
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):17-22. PubMed ID: 38072324
[TBL] [Abstract] [Full Text] [Related]
6. Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking.
Wukich DK; Frykberg RG; Kavarthapu V
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3754. PubMed ID: 38069459
[TBL] [Abstract] [Full Text] [Related]
7. Deep Learning-Based Interpretable AI for prostate T2W MRI Quality Evaluation.
Belue MJ; Law YM; Marko J; Turkbey E; Malayeri A; Yilmaz EC; Lin Y; Johnson L; Merriman KM; Lay NS; Wood BJ; Pinto PA; Choyke PL; Harmon SA; Turkbey B
Acad Radiol; 2024 Apr; 31(4):1429-1437. PubMed ID: 37858505
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of Testosterone Level of Seminal Vesicle Fluid in Patients With prostate cancer
Kashiwagi E; Shiota M; Inokuchi J; Tsukahara S; Imada K; Monji K; Goto S; Matsumoto T; Eto M
Anticancer Res; 2023 Sep; 43(9):4249-4254. PubMed ID: 37648320
[TBL] [Abstract] [Full Text] [Related]
9. A cross-sectional study on Chinese oncology nurses' knowledge of bone health among cancer patients.
Shan J; Lv S; Chen L; Li T; Li J; Wang S; Zhang C
Support Care Cancer; 2023 Aug; 31(8):501. PubMed ID: 37526757
[TBL] [Abstract] [Full Text] [Related]
10. Germline Genetic Testing After cancer Diagnosis.
Kurian AW; Abrahamse P; Furgal A; Ward KC; Hamilton AS; Hodan R; Tocco R; Liu L; Berek JS; Hoang L; Yussuf A; Susswein L; Esplin ED; Slavin TP; Gomez SL; Hofer TP; Katz SJ
JAMA; 2023 Jul; 330(1):43-51. PubMed ID: 37276540
[TBL] [Abstract] [Full Text] [Related]
11. Orchestration of miRNA Patterns by Testosterone and Dietary Tomato Carotenoids during Early prostate Carcinogenesis in TRAMP Mice.
Wan L; Thomas-Ahner JM; Pearl DK; Erdman JW; Moran NE; Clinton SK
J Nutr; 2023 Jul; 153(7):1877-1888. PubMed ID: 37187350
[TBL] [Abstract] [Full Text] [Related]
12. Unilateral Pelvic Lymph Node Dissection in prostate cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the Dogma.
Martini A; Wever L; Soeterik TFW; Rakauskas A; Fankhauser CD; Grogg JB; Checcucci E; Amparore D; Haiquel L; Rodriguez-Sanchez L; Ploussard G; Qiang P; Affentranger A; Marquis A; Marra G; Ettala O; Zattoni F; Falagario UG; De Angelis M; Kesch C; Apfelbeck M; Al-Hammouri T; Kretschmer A; Kasivisvanathan V; Preisser F; Lefebvre E; Olivier J; Radtke JP; Briganti A; Montorsi F; Carrieri G; Moro FD; Boström P; Jambor I; Gontero P; Chiu PK; John H; Macek P; Porpiglia F; Hermanns T; van den Bergh RCN; van Basten JA; Gandaglia G; Valerio M
J Urol; 2023 Jul; 210(1):117-127. PubMed ID: 37052480
[TBL] [Abstract] [Full Text] [Related]
13. Predictive Factors for Gleason Score Upgrading in Patients with prostate cancer after Radical prostatectomy: A Systematic Review and Meta-Analysis.
Wang Y; Chen X; Liu K; Liu R; Li L; Yin C; Song P
Urol Int; 2023; 107(5):460-479. PubMed ID: 36990065
[TBL] [Abstract] [Full Text] [Related]
14. Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk level.
Sorce G; Hoeh B; Flammia RS; Chierigo F; Hohenhorst L; Panunzio A; Nimer N; Tian Z; Gandaglia G; Tilki D; Terrone C; Gallucci M; Chun FKH; Antonelli A; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
Prostate; 2022 Sep; 82(12):1210-1218. PubMed ID: 35652586
[TBL] [Abstract] [Full Text] [Related]
15. Comparison between biparametric and multiparametric MRI diagnosis strategy for prostate cancer in the peripheral zone using PI-RADS version 2.1.
Zhang J; Xu L; Zhang G; Zhang X; Bai X; Ji Z; Xiao Y; Sun H; Jin Z
Abdom Radiol (NY); 2022 Aug; 47(8):2905-2916. PubMed ID: 35622121
[TBL] [Abstract] [Full Text] [Related]
16. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Pollack A; Karrison TG; Balogh AG; Gomella LG; Low DA; Bruner DW; Wefel JS; Martin AG; Michalski JM; Angyalfi SJ; Lukka H; Faria SL; Rodrigues GB; Beauchemin MC; Lee RJ; Seaward SA; Allen AM; Monitto DC; Seiferheld W; Sartor O; Feng F; Sandler HM
Lancet; 2022 May; 399(10338):1886-1901. PubMed ID: 35569466
[TBL] [Abstract] [Full Text] [Related]
17. Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity.
Cai R; Zhang X; Wang H; Cui T; Halmos G; Sha W; He J; Popovics P; Vidaurre I; Zhang C; Mirsaeidi M; Schally AV
Peptides; 2022 Apr; 150():170716. PubMed ID: 34952135
[TBL] [Abstract] [Full Text] [Related]
18. Changes in prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on prostate cancer Screening.
Leapman MS; Wang R; Park H; Yu JB; Sprenkle PC; Cooperberg MR; Gross CP; Ma X
JAMA Oncol; 2022 Jan; 8(1):41-47. PubMed ID: 34762100
[TBL] [Abstract] [Full Text] [Related]
19. Ketoconazole for the Treatment of Docetaxel-Naïve Metastatic Castration-Resistant prostate cancer (mCRPC): A Systematic Review.
Tresnanda RI; Pramod SV; Safriadi F
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3101-3107. PubMed ID: 34710984
[TBL] [Abstract] [Full Text] [Related]
20. Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for prostate cancer Treatment.
Wallach JD; Deng Y; McCoy RG; Dhruva SS; Herrin J; Berkowitz A; Polley EC; Quinto K; Gandotra C; Crown W; Noseworthy P; Yao X; Shah ND; Ross JS; Lyon TD
JAMA Netw Open; 2021 Oct; 4(10):e2130587. PubMed ID: 34677594
[TBL] [Abstract] [Full Text] [Related]
[Next]
